Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Oct;26(9):2187-99.

Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors

Affiliations

Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors

Nail Bulakbasi et al. AJNR Am J Neuroradiol. 2005 Oct.

Abstract

Purpose: The purpose of this study was to estimate the diagnostic accuracy of relative cerebral blood volume (rCBV) measurement in preoperative grading and differentiation of solitary intra-axial malignant brain tumors.

Methods: Thirty-six low-grade glial tumors (LGGTs), 22 high-grade glial tumors (HGGTs), and 17 metastases (METs) were prospectively evaluated by MR imaging and standard dynamic susceptibility contrast-enhanced gradient echo, echoplanar imaging during first pass of a bolus injection of contrast material. Normalized rCBV values from tumoral (rCBV(T)) and peritumoral (rCBV(P)) areas were calculated by standard software and statistically tested independently.

Results: The mean differences of rCBV(T) and rCBV(P) values between LGGT (2.30 +/- 1.12 and 1.18 +/- 0.24) and HGGT (5.42 +/- 1.52 and 2.17 +/- 0.82) (P < .001); HGGTs and METs (3.21 +/- 0.98 and 0.97 +/- 0.09) (P < .001); and LGGTs and METs (P < .05 and P < .001, respectively) were significant. No clear cutoff value was present. A clear rCBV(T) cutoff value of 2.6 was detected for differentiation of low- (1.75 +/- 0.38; LGA) versus high-grade (4.78 +/- 0.99; HGA) astrocytomas when nonastrocytic glial tumors were excluded. The rCBV(T) values were linearly correlated with degree of malignancy (r = 0.869; P < .001). Cutoff rCBV(P) values of 1.1 and 1.2 were quite effective in differentiation of METs from LGGTs and HGGTs, respectively. The overall efficacy of rCBV was higher in grading than in differentiation.

Conclusion: The diagnostic accuracy of rCBV measurement is higher in grading of glial brain tumors than in differentiation of HGGTs from solitary intra-axial METs. The astrocytic and nonastrocytic glial tumors have to be evaluated separately for precise grading.

PubMed Disclaimer

Figures

F<sc>ig</sc> 1.
Fig 1.
A 22-year-old man with low-grade oligoastocytoma (WHO II) in left frontoparietal lobe. A, Axial T2-weighted spin-echo image (2295/90) shows hyperintense mass involving left insula and temporal operculum. B, Tumor does not demonstrate contrast-enhancement on axial T1-weighted image (583/15), which suggests a LGGT. C, Gradient-echo axial perfusion MR image (627/30) with rCBV color overlay map shows a low rCBVT value of 1.50 and rCBVP value of 1.18, in keeping with LGGTs. D, Time-signal intensity and gamma-variate fitted curves from tumoral (red), peritumoral (blue), and normal (purple) areas show prominent decrease in signal intensity from tumoral area. Decreased signal intensity in peritumoral area is at least equal to that of normal gray matter.
F<sc>ig</sc> 2.
Fig 2.
A 22-year-old man with centrally located glioblastoma multiforme (WHO IV). A, Tumor shows heterogeneous hyperintensity with prominent peritumoral edema and/or tumoral infiltration (arrow) on axial T2-weighted SE image (2295/90). B, There is a significant heterogeneous enhancement in tumoral borders but not in peritumoral area (arrow) on axial T1-weighted image (583/15). C, Gradient-echo axial perfusion MR image (627/30) with rCBV color overlay map shows both high rCBVT value of 6.58 and rCBVP value of 2.21, which are consistent with HGGT. Peritumoral increased rCBV (arrow) shows tumoral infiltration outside the tumoral margins, which is not perceptible on T2- and contrast-enhanced T1-weighted images. D, Time-signal intensity and gamma-variate fitted curves from tumoral (red), peritumoral (blue), and normal (purple) areas show prominent decrease in signal intensity from tumoral and peritumoral areas, when compared with signal intensity of normal gray matter.
F<sc>ig</sc> 3.
Fig 3.
Scatter plots of the tumoral (AC) and peritumoral (DE) rCBV values of different tumor groups show that higher rCBV values are linearly related to higher degree malignancy. Lines are fitted by linear regression with 95% confidence interval. LGGT indicates low-grade glial tumor; HGGT, high-grade glial tumor; MET, metastasis; LGA, low-grade astrocytoma; LGMT, low-grade mixed tumor; HGA, high-grade astrocytoma; HGMT, high-grade mixed tumor; DAS, diffuse astrocytoma; PAS, pilocytic astrocytoma; AAS, anaplastic astrocytoma; GBM, glioblastoma multiforme.
F<sc>ig</sc> 4.
Fig 4.
Correlation plots of individual data points show linear correlation between tumoral and peritumoral rCBV values of different tumor groups. Lines are fitted by linear regression with 95% confidence interval.
F<sc>ig</sc> 5.
Fig 5.
A 51-year-old man with cystic METs from lung carcinoma located in right temporal lobe. A, Axial T2-weighted spin-echo image (2295/90), shows hyperintense cystic mass with peritumoral edema and/or infiltration (arrows). B, Axial contrast-enhanced T1-weighted image (583/15) reveals an irregularly ringlike enhancing mass without any peritumoral contrast enhancement (arrows). C, Gradient-echo axial perfusion MR image (627/30) with rCBV color overlay map shows a high rCBVT value of 3.05 but low rCBVP value of 1.05, which is consistent with METs. No rCBV increase is present on peritumoral area (arrows). D, Time-signal intensity and gamma-variate fitted curves from tumoral (red), peritumoral (green), and normal (blue) areas show prominent decrease in signal intensity from tumoral area. Decreased signal intensity in peritumoral area is at least equal to or less than that of normal gray matter.
F<sc>ig</sc> 6.
Fig 6.
A 20-year-old man with pilocytic astocytoma (WHO I) in the brain stem. A, Axial T2-weighted spin-echo image (2295/90), shows hyperintense mass involving brain stem without significant peritumoral edema. B, Tumor strongly enhances on postcontrast axial T1-weighted image (583/15), which suggests a HGGT. C, Gradient-echo axial perfusion MR image (627/30) with rCBV color overlay map shows no significant perfusion with a low rCBVT value of 1.14 and rCBVP value of 0.88, in keeping with a LGGT. Very low rCBVP value helps to differentiate it from low-grade astrocytomas (WHO II). D, Time-signal intensity and gamma-variate fitted curves from tumoral (red), peritumoral (blue), and normal (yellow) areas show prominent decrease in signal intensity from tumoral area. Decreased signal intensity in peritumoral area is similar to that of normal gray matter.

References

    1. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. AJNR Am J Neuroradiol 2004;25:214–221 - PMC - PubMed
    1. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–798 - PubMed
    1. Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29 - PubMed
    1. Wetzel SG, Cha S, Johnson G, et al. Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 2002;224:797–803 - PubMed
    1. Wong JC, Provenzale JM, Petrella JR. Perfusion MR imaging of brain neoplasms. AJR Am J Roentgenol 2000;14:1147–1157 - PubMed